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Received 22 March 2004; accepted 7 April 2004Summary The aim of this review was to identify systematically, criteria for
trismus in head and neck cancer, the evidence for risk factors for trismus and the
interventions to treat trismus. Three databases were searched (time period 1966 to
June 2003) for the text “trismus” or “restricted mouth opening”. Included in the
review were clinical studies (P 10 patients). Two observers independently assessed
the papers identified. In 12 studies nine different criteria for trismus were found
without justifying these criteria. Radiotherapy (follow-up: 6–12 months) involving
the structures of the temporomandibular joint and or pterygoid muscles reduces
mouth opening with 18% (sd: 17%). Exercises using a therabite device or tongue
blades increase mouth opening significantly (no follow-up), effect sizes (ES) 2.6 and
1.5 respectively. Microcurrent electrotherapy (follow-up 3 months) and pentoxif-








Trismus is a well known complication of head
and neck cancer treatment.1;2 The prevalence of
trismus after head and neck oncology treatment
ranges from 5% to 38%.3;4 This large range in
prevalence may be attributed to lack of uniform
criteria, visual assessment of trismus and retro-* Corresponding author. Address: Department of Rehabilita-
tion Medicine, University Hospital Groningen, P.O. BOX 30.001,
9700 RB Groningen, The Netherlands. Tel.: +31-50-3610297; fax:
+31-50-3611708.
E-mail address: p.u.dijkstra@rev.azg.nl (P.U. Dijkstra).
1368-8375/$ - see front matter c 2004 Elsevier Ltd. All rights reser
doi:10.1016/j.oraloncology.2004.04.003spective study design. Authors that do provide
criteria for trismus do not explain why they define
trismus in that specific way.3–6
Risk factors for trismus in head an neck oncology
have been described including tumours in the re-
gion of mouth closing muscles, radiation of the
temporomandibular joint or the muscles of masti-
cation, especially the medial pterygoid muscle but
again retrospective research designs may flaw the
conclusions of the studies.1
Many case studies are published to illustrate
treatment options for trismus.7–11 Also many re-
views and or clinical guide lines are published how
to prevent or treat trismus.1;12–16 However, theved.
880 P.U. Dijkstra et al.evidence supporting these prevention and treat-
ment programs is usually not provided. Thus, until
now the prevention and treatment of trismus
seems to be based on clinical experience and good
clinical practice.2;12;17
Aim of this review was to identify systematically
criteria for trismus, evidence for risk factors for
trismus and interventions to treat trismus.Methods
Literature databases, Medline, Embase, Cinhal
were searched for “trismus” and “restricted mouth
opening” in title, abstract and Mesh terms. Addi-
tionally in each database the free text words were
combined with the data base specific Mesh term for
“head and neck oncology” which includes the term
“oral oncology”. The time period over which was
searched was 1966 to June 2003.
Included in this review were clinical studies with
10 or more patients written in Dutch, German and
English. Excluded were non-systematic reviews,
clinical recommendations concerning, surgical
procedures, dental hygiene during oncology treat-
ment or exercise programs, letters to the editor,
case reports or case series (n < 10), studies not
involving patients, studies not concerning head and
neck oncology and papers written in other lan-
guages than the above mentioned.
All papers identified in the searches were re-
trieved from the library and were selected on the
basis of the inclusion criteria by the first author
(PD) after reading the abstract. The selected pa-
pers were copied and assessed independently by
two observers (PD and WK) according to the crite-
ria designed for this study. The following criteria
were assessed,
1. prospective study (yes, no),
2. inclusion criteria described (yes, no),
3. percentages or numbers of men and women in-
cluded in the study reported (yes, no),
4. descriptive statistics, mean and sd, or median
and inter quartile range, for age reported
(yes, no),
5. location of tumour reported with sufficient de-
tail, for instance floor of the mouth, tongue,
salivary glands etc. oropharyngeal or oral cavity
tumour is not detailed enough (yes, no),
6. baseline assessment of mouth opening (yes, no),
7. criteria for trismus described (yes, no),
8. trismus described in subjective terms, for in-
stance patients experience stiffness during
mouth opening or patients experience a re-
stricted mouth opening during eating (yes, no),9. trismus measured (yes, no),
10. measurement instrument described (yes, no),
11. repeated measurements performed to increase
reliability (yes, no),
12. percentage or number of patients with trismus
described (yes, no),
13. number of patients included in the study
(10–6 29, 30–6 99, 100 or more),
14. number of patients assessed for trismus
(10–6 29, 30–6 99, 100 or more).
The assessments of both observers were entered
in a database and Cohen’s j was calculated for
dichotomous data (criteria 1–12) and a linear
weighted j was calculated for ordinal data (criteria
13 and 14). A consensus meeting was held between
the two observers to discuss discrepancies in
assessment. Consensus was reached by means dis-
cussion if no consensus could be reached the
assessment of the third author (JR) would be
binding.Results
A total of 203 papers were identified in the da-
tabases. (References available on request at the
corresponding author.) Of these papers, 24 were
excluded because they were written in a foreign
language not understandable for the authors. Of
the remaining 179 papers the majority of papers
were clinical studies (n ¼ 77). The two observers
assessed these papers. During the assessment pro-
cess 11 additional papers were excluded because
they involved a survey among hospitals about
treatment regimes for head and neck oncology
patients, intubation procedures, reconstructive
surgery, trauma or trismus was not evaluated
(Table 1) (Appendix A: list of selected papers).
For the inter observer agreement of dichoto-
mous data Cohen’s j was 0.79 and for ordinal data
a linear weighted j was 0.88. One paper was only
assessed by the first author because it was identi-
fied after the consensus meeting.
The number and percentages of papers meeting
the different criteria are presented in Table 2.
When the scores of the criteria 1–12 are summed,
the mean sum score is 5.5 (sd: 1.6) the median sum
score is 5.0 (inter quartile range: 5–6.3). Sixteen
papers (24%) of the papers had a sum score of 7 or
more. In 12 studies nine different criteria for tris-
mus were found (Table 3). Some authors defined
trismus dichotomously as a mouth opening less
than 40 mm where as other authors defined trismus
as a mouth opening less than 20 mm. Three authors
Table 1 Types of publications found in the search
Publications Excluded % (n) Included % (n)












Case study or case series involving\10 patients 26.6% (54)




Clinical study involving P 10 patients 37.9% (77)
Relevant for the review 32.5% (66)
Not relevant 3.6% (11)
Survey of hospitals 1
Intubation procedure 1
Reconstructive surgery 2
Trismus not evaluated 6
Trauma 1
Total 67.5% (137) 32.5% (66)
a Papers published in other languages than English, German or Dutch.
Table 2 Percentage and number of publications fulfilling assessment criteria
Assessment criteria % (n)
Prospective study 27% (18)
Inclusion criteria of the study described 95% (63)
Percentages or numbers of men and women reported 80% (53)
Descriptive statistics for age reported 12% (8)
Location of tumour reported with sufficient detail 94% (62)
Baseline assessment of mouth opening 20% (13)
Criteria for trismus described 18% (12)
Trismus described in subjective terms 15% (10)
Trismus measured 12% (8)
Measurement instrument described 5% (3)
Repeated measurements performed 2% (1)
Percentage or number of patients with trismus described 86% (57)
Number of patients included in the studya
10–6 29 29% (22)
30–6 99 46% (30)
100 or more 26% (17)
Number of patients assessed for trismus
10–6 29 33% (22)
30–6 29 46% (30)
100 or more 21% (14)
a Due to rounding off the percentages exceed 100%.
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Table 3 Criteriaa for trismus according to different authors
Authors Mouth opening (mm) Lateral movements
Nguyen et al. (1988)27 \40 –
Steelman and Sokol (1986)b4 \35 –
Ichimura and Tanaka (1993)28 \35 –
Teo et al. (2000)29 \30 –
Chua et al. (2001)19 \25 –
Foote et al. (1990) [minimal trismus]30 20–30 –
Teo et al. (1998)31 \20 –
Chang et al. (2000) [severe trismus]32 \20 –
Jen et al. (2002)6 \20 –
Sakai et al. (1988)5
Normal \30 –
Moderately restricted 20–30 –
Severely restricted \10 –




Bertrand et al. (2000)c33
Grade 1 [40 Difference\25%
Grade 2 [30 Difference[25%
Grade 3 \25 No lateral movements
a Criteria are literally reproduced from the text.
b Steelman citing Gelb (1977).34 However, in that book no justification is provided for this criterion.
c Criteria for vertical as well as horizontal movements should be fulfilled.
882 P.U. Dijkstra et al.define trismus according to a more gradual scale of
which one also includes horizontal movements.
None of these studies provided justification for
these criteria.
Papers were selected for detailed review if they
met three assessment criteria; prospective study
design, base line assessment of trismus and mea-
surement of trismus.
Four paper fulfilled these criteria (Table 4).18–21
The assessment scores of these papers ranged from
6 to 11 points. Two cohort studies evaluated the
effects of Microcurrent therapy and Pentoxifylline
on mouth opening. One RCT analysed the effects of
different exercise programmes on mouth opening.
Finally one cohort study analysed the effects of
radiotherapy on mouth opening. To compare ef-
fects of the interventions effect sizes (ES) were
calculated:
ES ¼ meanchange=sdpretreatment
Exercises using a therabite device or tongblades
increase mouth opening significantly (no follow-
up), effect sizes (ES) 1.5 and 2.6 respectively.
Pentoxifylline (no follow-up) and Microcurrent
therapy (follow-up: 3 months) increase mouth sig-
nificantly. Effect size of both interventions was
0.3. Radiotherapy involving the structures of the
TMJ and or pterygoid muscles reduces mouthopening with 18% (sd: 17%) (follow-up: 6–12
months). For an overview of the finding see Table
4.
In a posthoc analysis the English abstracts or
titles were analysed of the papers that were
excluded because of the language they were
written in. Of the 24 papers there were three
case studies, four clinical recommendations or
reviews, four clinical studies of which one was
retrospective, and of nine publications the ab-
stracts were not available in the data bases.
Three did not have trismus as a topic of study
and one publication was similar to an English
publication of the same author, judged on the
basis of the abstract. Thus at the most 12 pub-
lications, three clinical studies and nine papers of
which the English abstracts were not available in
the data bases, might have been reviewed in this
study also.Discussion
Of all papers about trismus only 37% (66/179)
were clinical studies and were evaluated system-
atically. The overall quality of papers reviewed
was moderate to poor. Only 24% of the papers had
Table 4 Overview of the studies and their results
Author Study type Intervention/dosage Included n,
inclusion criteria










6 30 mm, radiation
completed\5 years
21 –
Therabite 13.6 (6.6) 8.6 to 18.7 2.6
Tongblades 6.0 (2.6) 3.6 to 8.4 1.5
Forced opening 5.4 (4.4) )0.05 to 10.9 1.1
Chua et al.
(2001)19
Cohort 8 weeks Pentoxifylline/
400 mg 3 times daily
20, mouth opening
6 25 mm, radiation
completedP 6 months






26, detectable fibrosis 23 3 months 2.6 (2.4) 0.1 to 3.6 0.3
Goldstein
et al. (1999)21
Cohort Radiotherapy 58, head and neck
oncology
58 6–12 months )18% (17%)






















884 P.U. Dijkstra et al.a sum score of more than half of the maximal
score. When three selection criteria (1, 6, and 9)
were applied only four studies fulfilled these cri-
teria.Assessment criteria
For systematic reviews analysing randomised
clinical trials, assessment criteria lists are avail-
able.22 We did not use these lists because we
were not only interested in RCTs but also in
prognostic research and cohort studies (observa-
tional studies). The criteria list used was based on
basic requirements of research methodology and
statistical description of the population under
study.
To assess risk factors and treatment strategies,
studies should at least be prospective because
otherwise several forms of bias (selection bias and
information bias) may be introduced in the study.
One of the principal requirements of a study is that
inclusion criteria are described. Additionally, the
study population should be described with suffi-
cient detail using adequate statistics. These ade-
quate statistics enable data pooling in case of
meta-analysis. Many studies describe the study
population with respect to age according to mean
and range, however, these statistics are inade-
quate for data pooling and, thus, should be re-
placed by mean and standard deviation or median
and inter quartile range.23 If risk factors for trismus
are to be analysed, sufficient detail should be
provided with respect to location of the tumour.
“Oropharyngeal tumour” or “tumour of the oral
cavity” tumour is not detailed enough. A tumour of
the buccal mucosa or cancer of the anterior floor of
the mouth may not lead to trismus at all, whereas a
tumour of the retromolar region may have a high
risk for inducing trismus, despite this they are both
tumours of the oral cavity. For evaluation of risk
factors for trismus or treatment effectiveness,
base line assessment of trismus is required. Be-
cause no gold standard exists as to which amount of
mouth opening should be regarded as trismus, cri-
teria for trismus were assessed. It appeared that a
wide range of criteria was used without docu-
menting why these specific criteria were used. It is
unclear when a restricted mouth opening results in
functional limitations such as problems with biting,
chewing, yawning, etc. To overcome this dilemma
trismus might be assessed in subjective terms such
as “Does your mouth opening feel restricted” or
“Are you limited in eating because of your mouth
opening”. Only 10 studies described trismus sub-
jectively.For adequate evaluation of trismus, mouth
opening should be measured, because visual
assessment of mouth opening is highly inaccurate
and leads to discrepancies between the assessed
mouth opening and the actual mouth opening. For
a reliable assessment of mouth opening, repeated
measurements should be performed.24
To obtain a rough estimation of the power of the
study and the drop out rates, the numbers of pa-
tients included and evaluated for trismus were as-
sessed.
Excluded studies
Cases studies were not included in this review
because they are highly susceptible for selection
bias and case studies are more or less anec-
dotal. They serve either to illustrate a rare case,
a rare complication or a new treatment strategy.
Case studies and case series may be interesting
from a clinical point of view but from a statis-
tical point of view case series and case studies
lack power. As cut off point for inclusionP 10
patients chosen for reasons explained previ-
ously.25 Expert reviews were excluded because it
is unclear which sources of information (data-
bases) were used to identify relevant papers
and how these papers were selected and how
these papers were critically assessed.26 The
same principles apply to the clinical recommen-
dations.
By restricting our review to papers written in
English, German and Dutch we introduced a
selection (language) bias. Which consequence this
type of bias has is not clear for the outcome of this
review. At the most 12 publications were excluded
from this review because of the language bias. If
these papers have a similar methodological quality
as the papers included in this review only 6% (4/66)
would have been selected for the detailed review
(prospective study design, base line assessment of
trismus and measurement of trismus). This may
resulted in one additional study in the detailed
review.Final selection of the studies
The final selection according to the three cri-
teria (prospective study design, base line assess-
ment of trismus and measurement of trismus) was
performed for several reasons. If risk factors for
trismus are to be identified one has to know whe-
ther trismus was absent before the exposure to the
risk factors (surgery and or radiotherapy) and in
which percentage of the patients at risk actually
Trismus in head and neck oncology 885developed trismus after the exposure. These
requirements can only be fulfilled in a prospective
study. For the selection of papers describing
therapeutic effects the previously mentioned
requirements must be met. Therefore it was not
possible to identify risk factors in the majority of
studies.
Exercises using a therabite device or tongblades
significantly increase mouth opening on short term,
the effect sizes were large. Pentoxifylline in-
creased mouth opening on short term and elec-
trotherapy increases mouth opening (follow-up: 3
months) but the effect sizes are small. Radiother-
apy involving the structures of the TMJ and or
pterygoid muscles reduces mouth opening with 18%
(sd: 17%).
The effect size relates the mean change as a
result of the exposure to the variance within the
population before the exposure. A large effect size
indicates that the mean change is large relative to
the variance before the exposure.Conclusion
Overall, trismus is usually not investigated pri-
marily but as a secondary outcome variable. In
general the quality of the studies analysed was
moderate. Despite the numerous papers written
the knowledge about trismus remains scarce. Only
four papers fulfilled three basic requirements. Ef-
fects of therapeutic interventions are scarcely
investigated. The effect sizes range from small to
large but the RCT with large effect sizes does not
have a follow-up. Research into criteria for tris-
mus, functional consequences of trismus, risk fac-
tors for trismus and interventions studies are
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